These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39121557)

  • 21. Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients.
    Diaz GA; Schulze A; Longo N; Rhead W; Feigenbaum A; Wong D; Merritt JL; Berquist W; Gallagher RC; Bartholomew D; McCandless SE; Smith WE; Harding CO; Zori R; Lichter-Konecki U; Vockley J; Canavan C; Vescio T; Holt RJ; Berry SA
    Mol Genet Metab; 2019 Aug; 127(4):336-345. PubMed ID: 31326288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal study of urea cycle disorders.
    Batshaw ML; Tuchman M; Summar M; Seminara J;
    Mol Genet Metab; 2014; 113(1-2):127-30. PubMed ID: 25135652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver transplantation for urea cycle disorders in pediatric patients: a single-center experience.
    Kim IK; Niemi AK; Krueger C; Bonham CA; Concepcion W; Cowan TM; Enns GM; Esquivel CO
    Pediatr Transplant; 2013 Mar; 17(2):158-67. PubMed ID: 23347504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urea cycle disorder presenting as bilateral mesial temporal sclerosis - an unusual cause of seizures: a case report and review of the literature.
    Wang FS; Goh DLM; Ong HT
    J Med Case Rep; 2018 Jul; 12(1):208. PubMed ID: 30007405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.
    Ah Mew N; Krivitzky L; McCarter R; Batshaw M; Tuchman M;
    J Pediatr; 2013 Feb; 162(2):324-9.e1. PubMed ID: 22901741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders.
    Pontoizeau C; Roda C; Arnoux JB; Vignolo-Diard P; Brassier A; Habarou F; Barbier V; Grisel C; Abi-Warde MT; Boddaert N; Kuster A; Servais A; Kaminska A; Hennequin C; Dupic L; Lesage F; Touati G; Valayannopoulos V; Chadefaux-Vekemans B; Oualha M; Eisermann M; Ottolenghi C; de Lonlay P
    Mol Genet Metab; 2020 Jun; 130(2):110-117. PubMed ID: 32273051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe hyperammonaemia in adults not explained by liver disease.
    Walker V
    Ann Clin Biochem; 2012 May; 49(Pt 3):214-28. PubMed ID: 22349554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines are not associated with metabolic events in children with urea cycle disorders.
    Morgan TM; Schlegel C; Edwards KM; Welch-Burke T; Zhu Y; Sparks R; Summar M;
    Pediatrics; 2011 May; 127(5):e1147-53. PubMed ID: 21482610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.
    Kölker S; Garcia-Cazorla A; Valayannopoulos V; Lund AM; Burlina AB; Sykut-Cegielska J; Wijburg FA; Teles EL; Zeman J; Dionisi-Vici C; Barić I; Karall D; Augoustides-Savvopoulou P; Aksglaede L; Arnoux JB; Avram P; Baumgartner MR; Blasco-Alonso J; Chabrol B; Chakrapani A; Chapman K; I Saladelafont EC; Couce ML; de Meirleir L; Dobbelaere D; Dvorakova V; Furlan F; Gleich F; Gradowska W; Grünewald S; Jalan A; Häberle J; Haege G; Lachmann R; Laemmle A; Langereis E; de Lonlay P; Martinelli D; Matsumoto S; Mühlhausen C; de Baulny HO; Ortez C; Peña-Quintana L; Ramadža DP; Rodrigues E; Scholl-Bürgi S; Sokal E; Staufner C; Summar ML; Thompson N; Vara R; Pinera IV; Walter JH; Williams M; Burgard P
    J Inherit Metab Dis; 2015 Nov; 38(6):1041-57. PubMed ID: 25875215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inborn Errors of Metabolism with Hyperammonemia: Urea Cycle Defects and Related Disorders.
    Summar ML; Mew NA
    Pediatr Clin North Am; 2018 Apr; 65(2):231-246. PubMed ID: 29502911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome and intervention of urea cycle disorders in Japan.
    Kido J; Nakamura K; Mitsubuchi H; Ohura T; Takayanagi M; Matsuo M; Yoshino M; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
    J Inherit Metab Dis; 2012 Sep; 35(5):777-85. PubMed ID: 22167275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving surveillance for hyperammonemia in the newborn.
    Vergano SA; Crossette JM; Cusick FC; Desai BR; Deardorff MA; Sondheimer N
    Mol Genet Metab; 2013; 110(1-2):102-5. PubMed ID: 23746553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and treatment of urea cycle disorders in adult patients].
    Maillot F; Blasco H; Lioger B; Bigot A; Douillard C
    Rev Med Interne; 2016 Oct; 37(10):680-684. PubMed ID: 27032484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Threshold for toxicity from hyperammonemia in critically ill children.
    Ozanne B; Nelson J; Cousineau J; Lambert M; Phan V; Mitchell G; Alvarez F; Ducruet T; Jouvet P
    J Hepatol; 2012 Jan; 56(1):123-8. PubMed ID: 21703182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.
    Diaz GA; Krivitzky LS; Mokhtarani M; Rhead W; Bartley J; Feigenbaum A; Longo N; Berquist W; Berry SA; Gallagher R; Lichter-Konecki U; Bartholomew D; Harding CO; Cederbaum S; McCandless SE; Smith W; Vockley G; Bart SA; Korson MS; Kronn D; Zori R; Merritt JL; C S Nagamani S; Mauney J; Lemons C; Dickinson K; Moors TL; Coakley DF; Scharschmidt BF; Lee B
    Hepatology; 2013 Jun; 57(6):2171-9. PubMed ID: 22961727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
    Lichter-Konecki U; Diaz GA; Merritt JL; Feigenbaum A; Jomphe C; Marier JF; Beliveau M; Mauney J; Dickinson K; Martinez A; Mokhtarani M; Scharschmidt B; Rhead W
    Mol Genet Metab; 2011 Aug; 103(4):323-9. PubMed ID: 21612962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders.
    Posset R; Garcia-Cazorla A; Valayannopoulos V; Teles EL; Dionisi-Vici C; Brassier A; Burlina AB; Burgard P; Cortès-Saladelafont E; Dobbelaere D; Couce ML; Sykut-Cegielska J; Häberle J; Lund AM; Chakrapani A; Schiff M; Walter JH; Zeman J; Vara R; Kölker S;
    J Inherit Metab Dis; 2016 Sep; 39(5):661-672. PubMed ID: 27106216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of peritoneal dialysis in neonates presenting with hyperammonaemia due to urea cycle defects and organic acidaemia.
    Celik M; Akdeniz O; Ozgun N
    Nephrology (Carlton); 2019 Mar; 24(3):330-335. PubMed ID: 29356227
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.